CLINICAL USES AND CONTROL OF RIFAMPICIN AND CLINDAMYCIN

被引:28
作者
PHILLIPS, I
机构
关键词
D O I
10.1136/jcp.24.5.410
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:410 / &
相关论文
共 57 条
[1]  
ACOCELLA G, 1967, 5 INT C CHEM S, V1, P87
[2]  
ARIOLI V, 1967, ARZNEI-FORSCHUNG, V17, P523
[3]   LABORATORY AND CLINICAL EVALUATION OF RIFAMPICIN [J].
ATLAS, E ;
TURCK, M .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1968, 256 (04) :247-&
[4]  
BALS MG, 1969, ARZNEI-FORSCHUNG, V19, P1285
[5]  
BARBER M, 1966, THERAPEUTIC USE ANTI, P28
[6]  
BAUDENS JG, 1969, PATHOL BIOL, V17, P391
[7]  
Berman J D, 1969, J Med Assoc Ga, V58, P155
[8]   RIFAMPIN - CLINICAL STUDIES WITH A NEW ANTIBIOTIC [J].
BRICKNER, PW .
JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS, 1969, 9 (04) :243-&
[9]   CHARACTERIZATION AND THIN-LAYER CHROMATOGRAPHIC QUANTITATION OF HUMAN METABOLITE OF 7-DEOXY-7(S)CHLOROLINCOMYCIN (U-21,251F) [J].
BRODASKY, TF ;
ARGOUDELIS, AD ;
EBLE, TE .
JOURNAL OF ANTIBIOTICS, 1968, 21 (05) :327-+
[10]   HEMODIALYSIS PROPERTIES OF CLINDAMYCIN (7-CHLORO-7-DEOXYLINCOMYCIN) [J].
CIMINO, JE ;
TIERNO, PM .
APPLIED MICROBIOLOGY, 1969, 17 (03) :446-&